uPA-anthrax toxin: promising antitumour activity

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1375, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumour vaccine promising in glioblastoma

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Everolimus [RAD 001], in combination with octreotide long-acting repeatable (LAR), shows promising antitumour activity

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity

By Galluzzo S   Santini D   Vincenzi B   Caccamo N   Meraviglia F   Salerno A   Dieli F   Tonini G  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 941-954

Informa Healthcare

Access to resources Recommend Favorite

Copper and iron complexes with antitumour activity

By Easmon Johnny  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 789-818

Informa Healthcare

Access to resources Recommend Favorite

17-AAG: mechanisms of antitumour activity

By Konstantinopoulos Panagiotis A   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1471-1474

Informa Healthcare

Access to resources Recommend Favorite